Logo image of INZY

INOZYME PHARMA INC (INZY) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:INZY - US45790W1080 - Common Stock

4 USD
+0.01 (+0.25%)
Last: 6/30/2025, 8:00:02 PM
3.99 USD
-0.01 (-0.25%)
After Hours: 6/30/2025, 8:00:02 PM
Buy % Consensus

72

ChartMill assigns a Buy % Consensus number of 72% to INZY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.85. This target is 71.21% above the current price.
INZY was analyzed by 13 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about INZY.
In the previous month the buy percentage consensus was at a similar level.
INZY was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
INZY Historical Analyst RatingsINZY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -59 -53 -47 -41 -35 -29 -23 -17 -11 -5 5 10 15

Price Target & Forecast

Price Low Median Mean High 4.004.044.086.8516.80 - 1.00% 2.00% 71.21% 320.00%
INZY Current Analyst RatingINZY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-05-16 Needham Downgrade Buy -> Hold
2025-05-16 Wells Fargo Downgrade Overweight -> Equal-Weight
2025-05-16 Jefferies Downgrade Buy -> Hold
2025-05-14 Needham Maintains Buy -> Buy
2025-04-10 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-08 Needham Reiterate Buy -> Buy
2025-03-12 Raymond James Maintains Outperform -> Outperform
2025-03-11 Needham Maintains Buy -> Buy
2025-03-11 Piper Sandler Maintains Overweight -> Overweight
2025-03-11 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-13 Wells Fargo Maintains Overweight -> Overweight
2025-01-13 Piper Sandler Maintains Overweight -> Overweight
2025-01-13 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-10 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-06 Needham Reiterate Buy -> Buy
2024-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-25 Needham Reiterate Buy -> Buy
2024-10-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-30 Wedbush Reiterate Outperform -> Outperform
2024-09-12 Stifel Initiate Buy
2024-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-06 Needham Reiterate Buy -> Buy
2024-07-26 Wedbush Reiterate Outperform -> Outperform
2024-07-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-30 Wells Fargo Initiate Overweight
2024-05-08 Needham Reiterate Buy -> Buy
2024-04-10 Needham Reiterate Buy -> Buy
2024-04-09 Needham Reiterate Buy -> Buy
2024-04-09 B of A Securities Maintains Buy -> Buy
2024-03-13 HC Wainwright & Co. Maintains Buy -> Buy

INOZYME PHARMA INC / INZY FAQ

What is the average price target for INOZYME PHARMA INC (INZY) stock?

13 analysts have analysed INZY and the average price target is 6.85 USD. This implies a price increase of 71.21% is expected in the next year compared to the current price of 4.


What is the consensus rating for INZY stock?

The consensus rating for INOZYME PHARMA INC (INZY) is 72.3077 / 100 . This indicates that analysts generally have a positive outlook on the stock.